2025 Breast Cancer Canada–AstraZeneca Research Grant: Mechanisms of Resistance and Therapy Response in Breast Cancer
Sponsor
Breast Cancer Canada, in partnership with AstraZeneca
For More Information
See Breast Cancer Canada's website [1]for full application information, guidelines, and LOI Application Form.
Description
Breast Cancer Canada (BCC) and AstraZeneca Canada (AZC) have partnered to offer two research grants advancing studies on treatment resistance, rapid relapses and long-term responses in HR+/HER2- and HER2+ metastatic breast cancer. This new partnership aims to drive progress in care for patients with late-stage breast cancer.
Eligibility
Submitted Project must include:
- Include at a minimum, 1 clinician and 1 form of breast cancer patient advocate (individual or organized group) as advisors to the research project.
- Incorporate principles of precision oncology
- Use of AI / machine learning
- Impact plan within next 3 years
- Detailed Budget
Funding Availability
Two Research Grants Available: Each Grant will include $100,000 of funding
Indirect Costs
0% per sponsor policy
Deadlines
If College-level review is required, your College will communicate its earlier internal deadlines.
| Type | Date | Notes |
|---|---|---|
External Deadline | Applicant to submit Letter of Intent using sponsor template to BCC directly via email at: research@breastcancerprogress.ca [2]. | |
Internal Deadline | Applicant to submit completed application with signed OR-5 form to Research Support Services via email at research.services@uoguelph.ca [3]. | |
External Deadline | Applicant to submit Full and Final Application to BCC directly via email at: research@breastcancerprogress.ca [2]. |